These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2467982)

  • 1. Ranitidine-induced changes in the renal and hepatic clearances of procainamide are correlated.
    Rocci ML; Kosoglou T; Ferguson RK; Vlasses PH
    J Pharmacol Exp Ther; 1989 Mar; 248(3):923-8. PubMed ID: 2467982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimethoprim inhibition of the renal clearance of procainamide and N-acetylprocainamide.
    Vlasses PH; Kosoglou T; Chase SL; Greenspon AJ; Lottes S; Andress E; Ferguson RK; Rocci ML
    Arch Intern Med; 1989 Jun; 149(6):1350-3. PubMed ID: 2471472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic drug interactions between triamterene and ranitidine in humans: alterations in renal and hepatic clearances and gastrointestinal absorption.
    Muirhead M; Bochner F; Somogyi A
    J Pharmacol Exp Ther; 1988 Feb; 244(2):734-9. PubMed ID: 3346844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances.
    Bauer LA; Black DJ; Lill JS; Garrison J; Raisys VA; Hooton TM
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1649-51. PubMed ID: 15793163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim alters the disposition of procainamide and N-acetylprocainamide.
    Kosoglou T; Rocci ML; Vlasses PH
    Clin Pharmacol Ther; 1988 Oct; 44(4):467-77. PubMed ID: 2458879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man.
    Somogyi A; Bochner F
    Br J Clin Pharmacol; 1984 Aug; 18(2):175-81. PubMed ID: 6091709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of procainamide and N-acetylprocainamide in protein-calorie malnutrition.
    Jung D; Nanavaty M; Prasad P
    Drug Metab Dispos; 1985; 13(3):359-63. PubMed ID: 2410212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic levels of intravenous procainamide in neonates: a retrospective assessment.
    Moffett BS; Cannon BC; Friedman RA; Kertesz NJ
    Pharmacotherapy; 2006 Dec; 26(12):1687-93. PubMed ID: 17125432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity of the cimetidine-induced alterations in the renal handling of organic substrates in humans. Studies with anionic, cationic and zwitterionic drugs.
    van Crugten J; Bochner F; Keal J; Somogyi A
    J Pharmacol Exp Ther; 1986 Feb; 236(2):481-7. PubMed ID: 3944769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging effects on the organic base transporter and stereoselective renal clearance.
    Ujhelyi MR; Bottorff MB; Schur M; Roll K; Zhang H; Stewart J; Markel ML
    Clin Pharmacol Ther; 1997 Aug; 62(2):117-28. PubMed ID: 9284847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of steady-state procainamide with H2-receptor antagonists cimetidine and ranitidine.
    Rodvold KA; Paloucek FP; Jung D; Gallastegui J
    Ther Drug Monit; 1987 Dec; 9(4):378-83. PubMed ID: 2447687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose dependent effect of cimetidine on procainamide disposition in man.
    Lai MY; Jiang FM; Chung CH; Chen HC; Chao PD
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):118-21. PubMed ID: 2457561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of N-acetylation of procainamide and renal clearance of N-acetylprocainamide by para-aminobenzoic acid in humans.
    Tisdale JE; Rudis MI; Padhi ID; Svensson CK; Webb CR; Borzak S; Ware JA; Krepostman A; Zarowitz BJ
    J Clin Pharmacol; 1995 Sep; 35(9):902-10. PubMed ID: 8786250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Simultaneous predictions of disposition kinetics of procainamide and its metabolite N-acetylprocainamide in rat by a physiological pharmacokinetic model].
    Liu XD; Deng N; Huang SK
    Yao Xue Xue Bao; 1991; 26(10):725-32. PubMed ID: 1726674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humans.
    Funck-Brentano C; Light RT; Lineberry MD; Wright GM; Roden DM; Woosley RL
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):364-73. PubMed ID: 2476614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined pharmacokinetic and pharmacodynamic model analysis for procainamide and its metabolite].
    Liu XQ; Huang SK
    Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):7-11. PubMed ID: 1719744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of age, renal function and heart failure on procainamide clearance and n-acetylprocainamide serum concentrations.
    Bauer LA; Black D; Gensler A; Sprinkle J
    Int J Clin Pharmacol Ther Toxicol; 1989 May; 27(5):213-6. PubMed ID: 2472362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of interaction of cimetidine and ranitidine with intravenous and oral midazolam.
    Greenblatt DJ; Locniskar A; Scavone JM; Blyden GT; Ochs HR; Harmatz JS; Shader RI
    Anesth Analg; 1986 Feb; 65(2):176-80. PubMed ID: 2935051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of selected general anesthetics on pharmacokinetic parameters of some antiarrhythmic drugs in rabbits. Part I. Procainamide and its active metabolite-N-acetylprocainamide.
    Orszulak-Michalak D
    Acta Pol Pharm; 1995; 52(2):141-6. PubMed ID: 8960244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
    Small DS; Farid NA; Li YG; Ernest CS; Payne CD; Salazar DE; Winters KJ
    Curr Med Res Opin; 2008 Aug; 24(8):2251-7. PubMed ID: 18786302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.